Tri Xenglu Xr 25mg/5mg/1000mg Tablet – Advanced Triple Therapy
Tri Xenglu Xr 25mg/5mg/1000mg Tablet – Advanced Triple Therapy
Description
Tri Xenglu Xr 25mg/5mg/1000mg Tablet – Extended-Release Formula for Enhanced Blood Sugar Control
Tri Xenglu Xr 25mg/5mg/1000mg Tablet is a prescription oral medication that combines empagliflozin 25mg, linagliptin 5mg, and metformin hydrochloride extended-release 1000mg. This innovative triple combination targets multiple pathways in type 2 diabetes: empagliflozin helps remove excess glucose through urine, linagliptin boosts insulin production and lowers glucagon levels, while metformin reduces glucose output from the liver and enhances insulin utilization. Designed for once-daily use, this extended-release tablet helps patients achieve better glycemic targets when combined with diet and physical activity. Its higher empagliflozin dose may offer additional benefits for cardiovascular and kidney protection in at-risk individuals, backed by clinical evidence demonstrating significant A1C reductions with a favorable tolerability profile.
